Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Biliary Tract Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    August 2021
  1. RUFFOLO LI, Jackson KM, Kuhlers PC, Dale BS, et al
    GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
    Gut. 2021 Aug 19. pii: gutjnl-2021-324109. doi: 10.1136/gutjnl-2021-324109.
    PubMed     Abstract available


    July 2021
  2. ARECHEDERRA M, Rullan M, Amat I, Oyon D, et al
    Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.
    Gut. 2021 Jul 20. pii: gutjnl-2021-325178. doi: 10.1136/gutjnl-2021-325178.
    PubMed     Abstract available


  3. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available


    May 2021
  4. LIU Q, Li B, Li Y, Wei Y, et al
    Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Gut. 2021 May 25. pii: gutjnl-2020-323565. doi: 10.1136/gutjnl-2020-323565.
    PubMed     Abstract available


    February 2021
  5. FROMME M, Schneider CV, Pereira V, Hamesch K, et al
    Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
    Gut. 2021 Feb 25. pii: gutjnl-2020-323729. doi: 10.1136/gutjnl-2020-323729.
    PubMed     Abstract available


  6. AHMED W, Joshi D, Harrison P, Reffitt D, et al
    Intraductal bile duct stents should be prioritised for removal during the pandemic.
    Gut. 2021 Feb 1. pii: gutjnl-2021-324105. doi: 10.1136/gutjnl-2021-324105.
    PubMed    


    January 2021
  7. GOEPPERT B, Stichel D, Toth R, Fritzsche S, et al
    Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Gut. 2021 Jan 19. pii: gutjnl-2020-322983. doi: 10.1136/gutjnl-2020-322983.
    PubMed     Abstract available


  8. AOKI S, Inoue K, Klein S, Halvorsen S, et al
    Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
    Gut. 2021 Jan 11. pii: gutjnl-2020-322493. doi: 10.1136/gutjnl-2020-322493.
    PubMed     Abstract available


    November 2020
  9. WAUTERS L, Ceulemans M, Lambaerts M, Accarie A, et al
    Association between duodenal bile salts and gastric emptying in patients with functional dyspepsia.
    Gut. 2020 Nov 25. pii: gutjnl-2020-323598. doi: 10.1136/gutjnl-2020-323598.
    PubMed    


  10. TAKEUCHI M, Vidigal PT, Guerra MT, Hundt MA, et al
    Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322540. doi: 10.1136/gutjnl-2020-322540.
    PubMed     Abstract available


  11. CALDERARO J, Kather JN
    Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322880. doi: 10.1136/gutjnl-2020-322880.
    PubMed     Abstract available


    April 2020
  12. DUCA FA, Lam TKT
    Bye, bye, bile: how altered bile acid composition changes small intestinal lipid sensing.
    Gut. 2020 Apr 17. pii: gutjnl-2020-320873. doi: 10.1136/gutjnl-2020-320873.
    PubMed    


  13. XIONG J, Wang Y, Chen G, Jin L, et al
    Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study.
    Gut. 2020 Apr 9. pii: gutjnl-2020-321052. doi: 10.1136/gutjnl-2020-321052.
    PubMed    


    March 2020
  14. SCHATTENBERG JM
    Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
    Gut. 2020 Mar 23. pii: gutjnl-2019-320355. doi: 10.1136/gutjnl-2019-320355.
    PubMed    


  15. TEOH AYB, Kitano M, Itoi T, Perez-Miranda M, et al
    Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1).
    Gut. 2020 Mar 12. pii: gutjnl-2019-319996. doi: 10.1136/gutjnl-2019-319996.
    PubMed     Abstract available


    February 2020
  16. HIGUCHI S, Ahmad TR, Argueta DA, Perez PA, et al
    Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice.
    Gut. 2020 Feb 28. pii: gutjnl-2019-319693. doi: 10.1136/gutjnl-2019-319693.
    PubMed     Abstract available


    January 2020
  17. DROPMANN A, Dooley S, Dewidar B, Hammad S, et al
    TGF-beta2 silencing to target biliary-derived liver diseases.
    Gut. 2020 Jan 28. pii: gutjnl-2019-319091. doi: 10.1136/gutjnl-2019-319091.
    PubMed     Abstract available


  18. ZHUANG Y, Xu HC, Shinde PV, Warfsmann J, et al
    Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injury.
    Gut. 2020;69:133-145.
    PubMed     Abstract available


    December 2019
  19. HARMS MH, de Veer RC, Lammers WJ, Corpechot C, et al
    Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
    Gut. 2019 Dec 16. pii: gutjnl-2019-319057. doi: 10.1136/gutjnl-2019-319057.
    PubMed     Abstract available


    October 2019
  20. RUHLEMANN MC, Solovjeva MEL, Zenouzi R, Liwinski T, et al
    Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species.
    Gut. 2019 Oct 25. pii: gutjnl-2019-320008. doi: 10.1136/gutjnl-2019-320008.
    PubMed    


    June 2019
  21. LIWINSKI T, Zenouzi R, John C, Ehlken H, et al
    Alterations of the bile microbiome in primary sclerosing cholangitis.
    Gut. 2019 Jun 26. pii: gutjnl-2019-318416. doi: 10.1136/gutjnl-2019-318416.
    PubMed     Abstract available


  22. CHAPMAN MH, Thorburn D, Hirschfield GM, Webster GGJ, et al
    British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
    Gut. 2019 Jun 1. pii: gutjnl-2018-317993. doi: 10.1136/gutjnl-2018-317993.
    PubMed     Abstract available


    April 2019
  23. MOOSER C, Ganal-Vonarburg SC
    Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches.
    Gut. 2019 Apr 26. pii: gutjnl-2019-318487. doi: 10.1136/gutjnl-2019-318487.
    PubMed    


  24. LEMOINNE S, Kemgang A, Ben Belkacem K, Straube M, et al
    Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Gut. 2019 Apr 19. pii: gutjnl-2018-317791. doi: 10.1136/gutjnl-2018-317791.
    PubMed     Abstract available


  25. PAN P, Zhao SB, Wang S, Li Z, et al
    Biliary dilatation in a 67-year-old woman: seeing is believing.
    Gut. 2019 Apr 17. pii: gutjnl-2018-318200. doi: 10.1136/gutjnl-2018-318200.
    PubMed    


  26. SINGHI AD, Nikiforova MN, Chennat J, Papachristou GI, et al
    Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.
    Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817.
    PubMed     Abstract available


    March 2019
  27. RUPP C, Hippchen T, Bruckner T, Kloters-Plachky P, et al
    Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
    Gut. 2019 Mar 25. pii: gutjnl-2018-316801. doi: 10.1136/gutjnl-2018-316801.
    PubMed     Abstract available


  28. KASPER P, Goeser T, Nierhoff D
    Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Gut. 2019 Mar 16. pii: gutjnl-2019-318502. doi: 10.1136/gutjnl-2019-318502.
    PubMed    


  29. LIAO L, Schneider KM, Galvez EJC, Frissen M, et al
    Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Gut. 2019 Mar 14. pii: gutjnl-2018-316670. doi: 10.1136/gutjnl-2018-316670.
    PubMed     Abstract available


    February 2019
  30. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.
    PubMed    


  31. MULLISH BH, McDonald JAK, Pechlivanis A, Allegretti JR, et al
    Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection.
    Gut. 2019 Feb 11. pii: gutjnl-2018-317842. doi: 10.1136/gutjnl-2018-317842.
    PubMed     Abstract available


  32. MERLEN G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, et al
    TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function.
    Gut. 2019 Feb 5. pii: gutjnl-2018-316975. doi: 10.1136/gutjnl-2018-316975.
    PubMed     Abstract available


    January 2019
  33. LI T, Guo H, Li H, Jiang Y, et al
    MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Gut. 2019 Jan 11. pii: gutjnl-2017-315318. doi: 10.1136/gutjnl-2017-315318.
    PubMed     Abstract available


    November 2018
  34. LIU Z, Alsaggaf R, McGlynn KA, Anderson LA, et al
    Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317504. doi: 10.1136/gutjnl-2018-317504.
    PubMed     Abstract available


    September 2018
  35. KREMER AE, Le Cleac'h A, Lemoinne S, Wolf K, et al
    Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis.
    Gut. 2018 Sep 18. pii: gutjnl-2018-317426. doi: 10.1136/gutjnl-2018-317426.
    PubMed    


    August 2018
  36. TAN LZ, Reilly CR, Steward-Harrison LC, Balouch F, et al
    Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
    Gut. 2018 Aug 21. pii: gutjnl-2018-316599. doi: 10.1136/gutjnl-2018-316599.
    PubMed    


    July 2018
  37. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed    


    June 2018
  38. LI M, Liu F, Zhang F, Zhou W, et al
    Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
    Gut. 2018 Jun 28. pii: gutjnl-2018-316039. doi: 10.1136/gutjnl-2018-316039.
    PubMed     Abstract available


    April 2018
  39. JAHN D, Marzioni M, Geier A
    Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
    Gut. 2018 Apr 20. pii: gutjnl-2018-316375. doi: 10.1136/gutjnl-2018-316375.
    PubMed    


  40. FUCHS CD, Paumgartner G, Mlitz V, Kunczer V, et al
    Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids.
    Gut. 2018 Apr 10. pii: gutjnl-2017-314553. doi: 10.1136/gutjnl-2017-314553.
    PubMed     Abstract available


  41. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Abstract available


    March 2018
  42. HIRSCHFIELD GM, Dyson JK, Alexander GJM, Chapman MH, et al
    The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
    Gut. 2018 Mar 28. pii: gutjnl-2017-315259. doi: 10.1136/gutjnl-2017-315259.
    PubMed     Abstract available


    August 2017
  43. ALBERTS R, de Vries EMG, Goode EC, Jiang X, et al
    Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
    Gut. 2017 Aug 4. pii: gutjnl-2016-313598. doi: 10.1136/gutjnl-2016-313598.
    PubMed     Abstract available


  44. JIAO N, Baker SS, Chapa-Rodriguez A, Liu W, et al
    Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Gut. 2017 Aug 3. pii: gutjnl-2017-314307. doi: 10.1136/gutjnl-2017-314307.
    PubMed     Abstract available


    July 2017
  45. DE VRIES EM, Wang J, Williamson KD, Leeflang MM, et al
    A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
    Gut. 2017 Jul 24. pii: gutjnl-2016-313681. doi: 10.1136/gutjnl-2016-313681.
    PubMed     Abstract available


  46. O'HARA SP, Karlsen TH, LaRusso NF
    Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
    Gut. 2017 Jul 21. pii: gutjnl-2017-314249. doi: 10.1136/gutjnl-2017-314249.
    PubMed    


    April 2017
  47. HUO X, Zhang X, Yu C, Cheng E, et al
    Aspirin prevents NF-kappaB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
    Gut. 2017 Apr 25. pii: gutjnl-2016-313584. doi: 10.1136/gutjnl-2016-313584.
    PubMed     Abstract available


  48. TRIVEDI PJ, Tickle J, Vesterhus MN, Eddowes PJ, et al
    Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.
    Gut. 2017 Apr 20. pii: gutjnl-2016-312354. doi: 10.1136/gutjnl-2016-312354.
    PubMed     Abstract available


    March 2017
  49. HANN A, Zizer E, Egger K, Allescher HD, et al
    Fatal outcome due to CO2 emboli during direct cholangioscopy.
    Gut. 2017 Mar 30. pii: gutjnl-2017-313988. doi: 10.1136/gutjnl-2017-313988.
    PubMed    


    February 2017
  50. TANG R, Wei Y, Li Y, Chen W, et al
    Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Gut. 2017 Feb 17. pii: gutjnl-2016-313332. doi: 10.1136/gutjnl-2016-313332.
    PubMed     Abstract available


  51. QURAISHI MN, Sergeant M, Kay G, Iqbal T, et al
    The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.
    Gut. 2017;66:386-388.
    PubMed    


    January 2017
  52. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Abstract available


    December 2016
  53. FERNANDEZ-BARRENA MG, Perugorria MJ, Banales JM
    Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis.
    Gut. 2016 Dec 16. pii: gutjnl-2016-312899. doi: 10.1136/gutjnl-2016-312899.
    PubMed    


    September 2016
  54. SINGH A, Smith PJ, Cropley IM, Planche KL, et al
    Gallstone mimicry: a rare cause of abdominal pain.
    Gut. 2016 Sep 29. pii: gutjnl-2016-312706. doi: 10.1136/gutjnl-2016-312706.
    PubMed    


  55. IWASAWA K, Suda W, Tsunoda T, Oikawa-Kawamoto M, et al
    Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312533. doi: 10.1136/gutjnl-2016-312533.
    PubMed    


  56. CAROTENUTO P, Fassan M, Pandolfo R, Lampis A, et al
    Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2016 Sep 12. pii: gutjnl-2016-312278. doi: 10.1136/gutjnl-2016-312278.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: